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Marketed under the name Antabuse, the drug acts primarily by irreversible inhibition of the enzyme acetaldehyde dehydrogenase, leading to unpleasant physical feelings accompanied by nausea or vomiting when ethanol is consumed. Recently, there has been renewed interest in DSF, primarily for its use in adjuvant therapies (clinical trials gov. identifier NCT00312819). DSF is also rapidly becoming considered as a potentially convincing anticancer drug. Reports have emerged recently of the induction of apoptosis in vitro in cancer cell lines generally thought to be chemotherapy-resistant, such as glioblastoma multiforme, by DSF either alone or in synergy with an anticancer agent (gemcitabine). 2, 3 However, the cytotoxic activity Scheme 1 observed in both cases was reliant on the presence of copper(II) salts and the active species responsible for the remarkable anticancer activity was not identified. Cen et al. reported a similar copper dependency in the induction of apoptosis in human melanoma cells by DSF/Cu 2+ . 4 Conticello et al. reported the effective use of DSF or DSF-copper(II) against human haematogical malignancies in vitro. 5 It is known that DSF can also be used with other transition metals to effect anti-cancer activity, 6, 7 though copper(II) is interesting due to its natural presence in vivo, requiring, in theory, only treatment of a patient with DSF alone to establish a prototype chemotherapy.
Dithiocarbamates are a class of sulfur-containing bidentate chelating ligands. The ability of the diethyldithiocarbamate ligands to complex a range of transition metal ions including Cu 2+ is wellknown. 8 We have previously been interested in using metaldithiocarbamate and metal-diselenocarbamate complexes as singlesource precursors 9 for various semiconductors for photovoltaic applications [10] [11] [12] [13] [14] [15] [16] as well as for nanocrystalline semiconducting quantum dots. 17, 18 Bifunctional dithiocarbamates have been used to functionalise the surface of noble metal nanoparticles with transition metal or lanthanide(III) complexes. 19, 20 The electronic properties of bis(N,Ndiethyldithiocarbamato)copper(II) (CuL 2 , Scheme 1) have been investigated by electron paramagnetic resonance (EPR) spectroscopy, giving insights into its self-association. 21 Similarly, the photochemistry of CuL 2 has been explored, with the complex displaying an intense ligand-to-metal charge transfer band (LMCT), with maximum absorbance at around 430 nm, a signature of its formation. 22, 23 It has been claimed that DSF forms CuL 2 species in solution upon addition of copper(II) salts. The chelating ligand, diethyldithiocarbamate, is the product of the two-electron reduction of DSF. Chen et al. noted a "dramatic colour change" on addition of copper(II) salts to DSF, probably due to the aforementioned LMCT transition in CuL 2 formed in situ. 24 Farmer and co-workers reported that the mechanism of formation of CuL 2 from a mixture of Cu(II) and DSF proceeded through the spontaneous decomposition of a small fraction of DSF in the presence of water to produce 30 electrons (Scheme 2, A) which then proceed to reduce 15 molecules of DSF to form the diethyldithiocarbamate, L, which then complexes copper(II) in situ to form CuL 2 in a theoretical 93% yield. 4 The main evidence presented for such a mechanism was an assay based on UV-Vis absorbance spectroscopy. The work was performed in biphasic systems (soluble Cu 2+ and solid DSF) formed on the addition of DSF to aqueous CuCl 2 , requiring extraction of reaction products into chloroform prior to analysis, as well as long reaction times (e.g. 24 h). Here we report the direct observation of CuL 2 species and study the EPR properties compared to isolated CuL 2 The reaction kinetics of the interaction of DSF with Cu 2+ ions are studied in both unbuffered and buffered (HEPES, pH 7.4) mixedsolvent solutions.
A 1:1 molar ratio of DSF and CuCl 2 was analysed by positive-mode electrospray ionisation mass spectrometry in order to observe directly if the dithiocarbamate-copper(II) complex, CuL 2 , is formed. We were able to identify the product in solution: a peak manifold was observed at m/z 359, consistent with CuL 2 (Supporting Information). The isotope pattern of the peak observed at m/z 359 confirmed the incorporation of a single copper centre as-compared to the theoretical pattern expected for protonated CuL 2 . Accurate mass determination of the [M+H] + peak by high-resolution mass spectrometry (HRMS, ES + ) gave a value that corresponded exactly to the theoretical mass of protonated CuL 2 (calc. for C 10 EPR spectroscopy was used to probe structural similarities between a solution of laboratory-synthesised CuL 2 (synthesised by the method of Jeliazkova et al., 22 characterisation data in Supporting Information) and a mixture of DSF and CuCl 2 in 1:1 molar ratio in a 95:5 THF:water glass at 80 K ( Figure 1 ) in order to compare the structure of the species formed in situ when stoichiometric amounts of DSF and CuCl 2 are mixed together in a solution. We also simulated the EPR spectrum of CuL 2 to compare both solutions to theory. The EPR spectra of both mixtures and the simulated spectrum of CuL 2 revealed striking similarities, thus suggesting that the species formed when DSF is mixed with a stoichiometric amount of Cu 2+ is CuL 2 . The EPR parameters obtained from experiment are in good agreement with the published EPR data of CuL 2 . UV-Vis absorption spectroscopy in a mixed solvent system (aqueous THF, 0.7% v/v) was used to probe complex formation under steady-state and kinetic conditions. The LMCT transition of CuL 2 , which has an absorbance maximum at ca. 425 nm can be used as a spectroscopic handle to confirm the formation of CuL 2 species in situ when CuCl 2 and DSF are mixed in stoichiometric amounts. Titration of a solution of DSF in THF into a solution of copper(II) chloride in water demonstrated the steady growth of the LMCT absorption band, with peak maxima at 425 nm, characteristic of CuL 2 (Supporting Information). It is important that the solution remained homogeneous throughout the titration, ensuring that all the species formed were analysed. Kinetic studies of the using a 1:1 ratio of DSF:CuCl 2 exhibited a marked increase in the LMCT absorption at 425 nm to a plateau in around 150 min, indicating that complexation was fully complete only after this time (Figure 2 ). Isosbestic points in absorbance spectra give important information regarding the relationship between two species in solution. The presence of three well-defined isobestic points at 250 nm, 290 nm and 325 nm demonstrate that the copper(II)-bound and unbound ligand (i.e. Cu(II)-DSF and DSF) species are, most likely, related linearly by stoichiometry as expected.
Continuous variation plots using the LMCT electronic transition at 425 nm were used to further probe the stoichiometry of the complex formed between CuCl 2 and DSF in situ. (Figure 3 and Supporting Information for calculation of intersect and calculation of random error in linear regression). This means therefore that the overall stoichiometry of the system is in slight excess of DSF; a value of x = 0.50 corresponds to CuL 2 , thus the slight shift to x > 0.5 indicates a slight stoichiometric excess of DSF in the system. This overall stoichiometry is fully consistent with the stoichiometric equations which were subsequently derived from kinetic experiments in buffered solution (vide infra and Scheme 2, C).
UV-Vis absorption spectroscopy allowed the determination of a rate law for the reaction in unbuffered solution using the method of initial rates. 26 In this method, initial rates for the reaction being studied (v 0 ) are measured for reactants isolated by concentration and plots of log v 0 vs. log [R] (where [R] is the concentration of the reactant being studied) give straight lines with slope equal to the order of the reaction with respect to reactant R, and y-intercepts equivalent to logk, where k is the observed rate constant with respect to the isolated reactant. The rate of formation of CuL 2 -type species can thus be quantified by UV-Vis spectroscopy using the absorbance of the LMCT transition, and the orders of reaction determined for both DSF and Cu. Initial rates of reaction (v 0 ; t ≤ 5 min) were measured for a range of concentrations of DSF and Cu 2+ in a mixed solvent system (aqueous THF, 0. 4 disproportionation of DSF in water (i.e. pseudo firstorder kinetics) to release the electrons required for reduction, followed by complexation of copper(II) and acidic runaway would indeed be pseudo first-order with respect to DSF, and probably ratelimiting, assuming that the complexation step is relatively rapid in comparison. with respect to isolated DSF and k = 4.851 × 10 -5 mol -1 dm 3 s -1 with respect to isolated copper. We propose that the mechanism in buffered solutions occurs via reduction of Cu 2+ to Cu + by the initial oxidation of DSF to the bitt-4 2+ intermediate 4 which is followed by a rapid two-electron reduction of another DSF molecule by two Cu The overall stoichiometry of the reaction with respect to Cu 2+ :DSF ratio is ca. 0.9:1.0, as observed in the Job plot (vide supra). It is likely that this may be the mechanism for the reaction of DSF with copper(II) ions under biological conditions. It is also likely that the release of copper(I) ions during the formation of CuL 2 and the catastrophic decomposition of bitt-4 2+ could lead to massive oxidative stress on cells in vitro assays and result in the apoptosis observed.
Scheme 2

Conclusions
In conclusion, the interaction of DSF with copper(II) ions in solution has been comprehensively studied. Mass spectrometry and EPR suggest the species formed in solution is CuL 2 where L = (S 2 CNEt 2 ). UV-Vis absorption spectroscopy titrations at steady-state demonstrate the growth of the characteristic LMCT absorbance for this species. Kinetic studies using UV-Vis absorption spectroscopy to monitor the LMCT absorption band demonstrate that the rate law is first-order with respect to DSF in unbuffered solution, which suggests a rate-limiting step reliant only on the concentration of DSF within the mixture. The rate law changes to a first order dependence on both DSF and copper(II) ions in buffered solutions, with a mechanism for the formation of CuL 2 involving an oxidised ligand intermediary, bitt-4 2+ , and copper(I) ions. In this sense, DSF may behave noninnocently. We have, therefore, confirmed the first step of the mechanism proposed previously to this study, 4 which can involve a pH runaway, as well as proposing a mechanism for the altered kinetics observed in buffered solutions. These observations potentially have serious implications regarding the potential use of DSF as a therapeutic agent in vivo. It is likely that in in vitro assays, on addition of the copper(II) ions to the media, the cells are exposed to a rapid decomposition of DSF to bitt-4 2+ and copper(I) ions with a catastrophic release of reactive oxygen species such as H 2 O 2 arising from Fenton chemistry, the latter which are known to cause apoptosis. 27 The role of reactive oxygen species in apoptosis of cancer cells treated with DSF and DSF-copper(II) cocktails has not escaped the attention of researchers though a potential explanation for this has, until now, been elusive. 5 The oxidation reactions suggested here, as we have seen, are likely to be relatively rapid and thus may be highly cytotoxic (produces a greater dose of H 2 O 2 over time). 28 Therefore, the induction of apoptosis in tumour cells by a copper(II) DSF cocktail in vivo is difficult to envisage as it is probably not caused by a discrete copper-DSF complex but rather is due to a reaction. Obviously, if the product of this reaction were a therapeutic molecule there would be a candidate drug that could be delivered in vivo but this does not seem to be the case. The situation is rather similar to the recent case of cisplatin solvated in DMSO, where reactivity of the solvent medium may have produced misleading results from in vitro assays. 29 Care must therefore be taken when it is suggested that the anticancer activity of DSF in combination with copper(II) observed in vitro can be translated in vivo. 
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